Coronary heart disease is a condition in which plaque builds up in the coronary arteries, reducing blood flow to the heart muscle. It can cause chest pain, shortness of breath, heart attack, and heart failure.
A 30-year study of nearly 200,000 adults found that diet quality matters more than macronutrient ratios for heart health, with both healthy low-carb and low-fat diets reducing coronary heart disease risk equally.
Vir Biotechnology reported Q4 EPS of ($0.31), beating estimates by $0.23, with revenue of $64.07 million. The company announced a global strategic collaboration with Astellas for VIR-5500 and reported $781.6 million in cash and investments.
Vir Biotechnology announced a global strategic collaboration with Astellas for VIR-5500, a PSMA-targeted dual-masked T-cell engager for prostate cancer, and reported $781.6 million in cash and investments as of December 31, 2025.
Phase III SMART trial data show clesrovimab maintained consistent safety and efficacy in high-risk children across two RSV seasons, with no drug-related serious adverse events reported in either season.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07514611 |
Weight Loss Via Intelligent Guidance in Patients With Coronary Heart Disease and Obesity: a Randomized Clinical Trial |
RECRUITING | NA |
| NCT07323979 |
The Effects of Different Prone Positioning Angles on Cardiopulmonary Function in Children After Congenital Heart Disease Surgery: A Randomized Controlled Trial |
COMPLETED | NA |
| NCT07034274 |
National Tunisian Clinical Registry on CardioVascular Secondary Prevention Clinical |
COMPLETED | |
| NCT03496363 |
Hypothyroidism With Congenital Heart Disease (CHD) |
UNKNOWN | |
| NCT02440893 |
Understanding the Effect of Metformin on Corus CAD (or ASGES) |
COMPLETED | |
| NCT02405754 |
Clinical Utility of an Age, Sex, and Gene Expression Score (ASGES or Corus CAD) in African American Patients. |
COMPLETED | |
| NCT02223286 |
Understanding Clinician Utilization of Corus CAD (Age/Sex/Gene Expression Score - ASGES) in Clinical Decision Making |
COMPLETED | |
| NCT02158754 |
Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making |
WITHDRAWN | |
| NCT01677156 |
A Registry to Evaluate Patterns of Care Associated With the Use of Corus CAD (or ASGES) in Primary Care Settings |
COMPLETED | |
| NCT01594411 |
PCP Use of a Gene Expression Test (Corus CAD or ASGES) in Coronary Artery Disease Diagnosis |
COMPLETED |
